Reassessment of the Risk of Hemolytic Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With a Regimen Containing Venetoclax
Clinical trial NCT07691047 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07691047
- Sponsor
- Private Hospital of Confluent, France
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2029-07-31
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.